Stock AVCN AVICANNA INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Avicanna Inc.

Equities

AVCN

CA05368K1003

Market Closed - Toronto S.E.
Other stock markets
 20:59:58 30/04/2024 BST 		5-day change 1st Jan Change
0.36 CAD -2.70% Intraday chart for Avicanna Inc. -7.69% +2.86%
04-19 Avicanna Raises About $2.1 Million in Non-brokered Private Placement MT
04-18 Avicanna Inc. announced that it has received CAD 2.125584 million in funding CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Avicanna Raises About $2.1 Million in Non-brokered Private Placement
MT
Avicanna Announces Closing of Non-brokered Private Placement
AQ
Avicanna Inc. announced that it has received CAD 2.125584 million in funding
CI
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
AQ
Avicanna Inc. Announces Completion of Topical Gel Observational Real-World Evidence Study
CI
Transcript : Avicanna Inc., 2023 Earnings Call, Apr 02, 2024
Avicanna's Q4 Loss Narrows, Revenue Grows
MT
Avicanna Brief: Reporting $16.8 Million in 2023 Revenue, representing an increase of 314% from 2022
MT
Avicanna Reports Full Year 2023 Audited Financial Results 
AQ
Avicanna Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Avicanna Announced Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
MT
Avicanna Brief: Announcing Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
MT
Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
AQ
Avicanna Inc Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
CI
Avicanna To Hold Full Year 2023 Earnings Conference Call
AQ
ThreeD Capital Inc. Announces New YouTube Channel
MT
Avicanna Hosts Symposium on Cannabinoid-based Medicine  
AQ
Avicanna Reports New Research Collaboration With Multi-national European-based Pharmaceutical Firm; Down 5.6%
MT
Avicanna Reports New Research Collaboration With Multi-national European-based Pharmaceutical Firm
MT
Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AVCN Stock
  4. News Avicanna Inc.